You are here


Original articles

Barth H., Schnober E.K., Neumann-Haefelin C., Thumann C., Zeisel M.B., Diepolder H.M., Hu Z., Liang T.J., Blum H.E., Thimme R., Lambotin M., Baumert T.F. Scavenger receptor Class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J. Virol., 2008, 82, 3466-79.

Wolf M., Dimitrova M., Baumert T.F., Schuster C. The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expression. Nucleic Acids Res., 2008, 36, 3054-64.

Meyer F., Dimitrova M., Jedrzejenska J., Arntz Y., Schaaf P., Frisch B., Voegel J.C., Ogier J. Relevance of bi-functionalized polyelectrolyte multilayers for cell transfection. Biomaterials., 2008, 29, 618-24.

Hafkemeyer P., Brinkmann U., Brinkmann E., Pastan I., Blum H. E., Baumert T.F. Pseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cells. World J. Gastroenterol., 2008, 14, 2810-7.

Deschamps M., Robinet E. , Certoux J.M., Mercier P., Sauce D., De Vos J., Montcuquet N., Bonyhadi M., Reme T., Tiberghien P., Ferrand C. Transcriptome of retrovirally transduced CD8(+) lymphocytes: Influence of cell activation, transgene integration, and selection process. Mol. Immunol., 2008, 45, 1112-25.

Fafi-Kremer S., Morand P., Barranger C., Bargues G., Magro S., Bes J., Bourgeois P., Joannes M., Seigneurin J.M. Evaluation of the Epstein-Barr Virus R-Gene Quantification Kit in Whole Blood with different Extraction Methods and PCR Platforms. J. Mol. Diag., 2008, 10, 78-84.

Mercier-Letondal P., Montcuquet N., Sauce D., Certoux J.M., Jeanningros S., Ferrand C., Bonyhadi M., Tiberghien P., Robinet E. Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio. Cytotherapy, 2008, 10, 275-88.

Bennour E., Ferrand C., Remy-Martin J.P., Certoux J.M., Gorke S., Qasim W., Gaspar B., Baumert T.F., Duperrier A., Deschamps M., Fehse B., Tiberghien P., Robinet E. Abnormal expression of the only CD34 part of a transgenic CD 34/Herpes Simplex Virus-thymidine kinase fusion protein is associated with ganciclovir resistance. Hum. Gene Ther., 2008, 19, 699-709.

Bouzgarrou N., Hassen E., Schvoerer E., Stoll-Keller F., Bahri O., Chikh I., Maamouri N., Mammi N., Saffar H., Triki H., Chouchane L. Association of Interleukin-18 polymorphisms and plasma level with outcome of chronic HCV infection. J. Med. Virol., 2008, 80, 607-14.

Thumann C., Schvoerer E., Abraham J.D., Bohbot A., Stoll-Keller F., Aubertin A.M., Kieny M.P. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation. Gastroentérol. Clin. Biol., 2008, 32, 59-68.

Espuelas S., Thumann C., Heurtault B., Schuber F., Frisch B. Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes. Bioconjug. Chem., 2008, 19, 2385-93.

Lan L., Gorke S., Rau S.J., Zeisel M.B., Hildt E., Himmelsbach K., Carvajal-Yepes M., Huber R., Wakita T., Schmitt-Graeff A., Royer C., Blum H.E., Fischer R., Baumert T.F. Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J. Immunol., 2008, 181, 4926-35.

Mercier-Letondal P., Deschamps M., Sauce D., Certoux J.M., Milpied N., Lioure B., Cahn J.Y., Deconinck E., Ferrand C., Tigerghien P., Robinet E. Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response? Hum. Gen. Ther., 2008, 19, 937-50.

Imbert I., Snijder E.J., Dimitrova M., Guillemot J.C., Lecine P., Carnard B. The SARS-Coronavirus PLnc domain of nsp3 as a replication/transcription scaffolding protein. Virus Res., 2008, 133, 136-48.

Morand P., Fafi-Kremer S., Mansuy L., Schmitt E., Weinbreck N., Kremer S. Neuroimaging of Epstein-Barr Virus Infections in Children. Pediatr. Radiol., 2008, 38, 354-5.

Haberstroh A., Schnober E.K., Zeisel M.B., Carolla P., Barth H., Blum H.E., Cosset F.L., Koutsoudakis G., Bartenschlager R., Union A., Depla E., Owsianka A., Patel A.H., Schuster C., Stoll-Keller F., Doffoel M., Dreux M., Baumert T.F. Neutralizing host responses in hepatitis C virus infection target viral entry at post binding steps and membrane fusion. Gastroenterology, 2008, 135, 1719-1728.

Dimitrova M., Affolter C., Meyer F., Nguyen I., Richard D.G., Schuster C., Bartenschlager R., Voegel J.C., Ogier J., Baumert T.F. Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films. Proc. Natl. Acad. Sci., USA, 2008, 105, 16320-16325.

Schramm F., Soulier E., Royer C., Weitten T., Fafi-Kremer S., Brignon N., Meyer N., Ellero B., Woehl-Jaegle M.L., Meyer C., Wolf P., Doffoel M., Baumert T.F., Stoll-Keller F., Schvoerer E. Frequent compartmentalization of hepatitis C virus with leukocyte-related amino acids in teh setting of liver transplantation. J. Infect. Dis., 2008, 198, 1656-1666.

Montcuquet N., Mercier-Letondal P., Perruche S., Duperrier A., Couturier M., Bouchekioua A., Bonyhadi M., Ferrand C., Tiberghien P., Robinet E. Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells. Immunology, 2008, 125, 320-30.

Fuks D., Pessaux P., Tuech J.J., Mauvais F., Bréhant O., Dumont F., Chatelain D., Yzet T., Joly J.P., Lefebure B., Deshpande S., Arnaud J.P., Verhaeghe P., Regimbeau J.M. Management of patients with carcinoma of the right colon invading the duodenum or pancreatic head. Int. J. Colorectal. Dis., 2008, 23, 477-81.

Kato T., Choi Y., Elmowalid G., Sapp R., Barth H., Furusaka A., Mishiro S., Wakita T., Krawczynski K., Liang T.J. Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenecity and emergence of an adaptive mutation. Hepatology, 2008, 48, 732-40.

Lermite E., Pessaux P., Teyssedou C., Etienne S., Brehant O., Arnaud J.P. Effect of preoperative endoscopic biliary drainage on infectious morbidity after pancreatoduodenectomy: a case-control study. Am. J. Surg., 2008, 195, 442-6.

Oussoultzoglou E., Panaro F., Rosso E., Zeca I., Bachellier P., Pessaux P., Jaeck D. Use of BiClamp decreased the severity of hypocalcemia after total thyroidectomy compared with LigaSure: a prospective study. World J. Surg., 2008, 32, 1968-73.

Oussoultzoglou E., Rosso E., Fuchshuber P., Stefanescu V., Diop B., Giraudo G., Pessaux P., Bachellier P., Jaeck D. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study. Arch. Surg., 2008, 143, 1150-8.

Paulet E., Aube C., Pessaux P., Lebigot J., Lhermitte E., Oberti F., Ponthieux A., Cales P., Ridereau-Zins C., Pereira P.L. Factors limiting complete tumor ablation by radiofrequency ablation. Cardiovasc. Intervent. Radiol., 2008, 31, 107-15.

Stöhr S.W., Barber T., Bart P.A., Harari A., Moog C., Ciuffreda D., Cellerai C., Cowen M., Gamboni R., Burnet S., Legg K., Brodnicki E., Wolf H., Wagner R., Heeney J., Frachette M.J., Tartaglia J., Babiker A., Pantaleo G., Weber J. EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone. Vaccine, 2008 26, 3162-3174.

Harari A., Bart P.A., Stöhr W., Tapia G., Garcia M., Medjitna-Rais E., Burnet S., Cellerai C., Erlwein O., Barber T., Moog C., Liljestrom P., Wagner R., Wolf H., Kraehenbuhl M., Esteban J., Heeney M.J., Frachette J., Tartaglia S., Mccormack J.P., Babiker A., Weber J., Pantaleo G. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J. Exp. Med., 2008, 205, 63-77.

Collette S., Bonnetain F., Paoletti X., Doffoel M., Bouche O., Raoul J.L., Rougier P., Masskouri F., Bedenne L., Barbare J. Prognosis of advanced hepatocellular carcinoma : comparison of 3 staging systems in two French clinical trials. Ann. Oncology, 2008, 19, 1117-26.

Doffoel M., Bouche O., Vetter D., Abergel A., Fratte S., Grange J.D., Stremsdoerfer N., Blanchi A., Bronowicki J.P., Caroli-Bosc F.X., Causse X., Masskouri F., Rougier P., Bedenne L. (Fédération Francophone de Cancérologie Digestive (FFCD 9402). Multicenter randomized phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolization for unresectable hepatocellular carcinoma in cirrhotic patients. Eur. J. Cancer, 2008, 44, 528-38.

Bonnetain F., Paoletti X., Colette S., Doffoel M., Bouche O., Raoul J.L., Rougier P., Masskouri F., Barbare J.C., Bedenne L. Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma : results from two French clinical trials. Qual. Life Res., 2008, 17, 831-843.

Reviews, editorials etc.

Fafi-Kremer S., Stoll-Keller F., Baumert T.F. Efficient postexposure prophylaxis by hepatitis A vaccine. Hepatology, 2008, 47, 1416-8.

Barth H., Robinet E., Liang T.J., Baumert T.F. Mouse models for the study of HCV infection and virus-host interactions. J. Hepatol., 2008, 49, 134-42.

Zeisel M.B., Cosset F.L., Baumert T.F. Host neutralizing responses and pathogenesis of hepatitis C virus infection. Hepatology, 2008, 48, 299-307.

Fafi-Kremer S., Zeisel M.B., Schvoerer E., Soulier E., Habersetzer F., Wolf P., Doffoel M., Baumert T.F., Stoll-Keller F. Neutralizing antibodies in hepatitis C virus infection. Gastroentérol. Clin. Biol., 2008, 32, 491-8.

Lupberger J., Brino L., Baumert T.F. RNAi – a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle. J. Hepatol., 2008, 48, 523-5.

Lupberger J., Zeisel M.B., Haberstroh A., Schnober E.K., Krieger S., Soulier E., Thumann C., Royer C., Fafi-Kremer S., Schuster C., Stoll-Keller F., Blum H.E., Baumert T.F. Virus-host interactions during hepatitis C virus entry – Implications for pathogenesis and novel treatment approaches. In: “Virologica Sinica”, (X. Chen, M. Lu and D. Yang eds.), 2008, 22, 124-131.

Schramm F., Moenne-Loccoz R., Fafi-Kremer S., Soulier E., Royer C., Brignon N., Ellero B., Woehl-Jaegle M.L., Meyer C., Wolf P., Doffoel M., Gut J.P., Baumert T.F., Stoll-Keller F., Schvoerer E. Study of hepatitis C virus leukotropism by characterization of viral quasispecies in the liver transplantation setting. Pathol. Biol., 2008, 56, 487-491.

Schvoerer E., Massue J.P., Gut J.P., Stoll-Keller F. Climate change: impact on viral diseases. The Open Epidemiology Journal, 2008, 1, 45-48.

Stoll-Keller F., Fafi-Kremer S., Wolf P., Doffoel M., Baumert T. Novel strategies for preventing viral hepatitis C recurrence after liver transplantation. Bull. Acad. Natl. Med., 2008, 192, 1657-67.

Moog C. Immune responses that correlate with HIV-1 protection? AIDS, 2008, 22, 1461-2.

Zarski J.P., Doffoel M., Filoche B., Marcellin P., Samuel D., Bedossa P. Hepatitis C, cirrhosis and hepatocellular carcinoma. Gastroenterol. Clin. Biol., 2008, 32, S117-20.